Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
about
Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal functionPresent and future in the treatment of diabetic kidney diseaseAntihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone systemUpdates in hyperkalemia: Outcomes and therapeutic strategies.C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.Slowing progression of chronic kidney diseaseSafety of ACE inhibitor therapies in patients with chronic kidney disease.Angiotensin blockade in late autosomal dominant polycystic kidney disease.Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease.Effects of Ramipril and Telmisartan on Plasma Concentrations of Low Molecular Weight and Protein Thiols and Carotid Intima Media Thickness in Patients with Chronic Kidney DiseaseManagement of hyperkalaemia in chronic kidney disease.Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy.Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.[Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis].
P2860
Q26795398-07706EBC-1B8F-4235-8C64-78997BBEE2FBQ26864133-27F48E07-2CF4-4DA9-B4DF-5F96DAD2AA1DQ26865691-0A0B93F0-CFEF-42A6-BD7A-559A12779FA5Q30245585-12080548-811F-493F-A0B8-9CE6F4BE30B0Q33620560-C95104B9-A2E6-4AEC-BCED-E7227509DE02Q33873241-B9E4A909-1841-4424-99A6-A784F9BF38B7Q34434606-BCC5E08F-0C96-4B6D-B0C4-C6A8807C5DF0Q34836649-4FD20E47-A06E-4B6F-9A68-83547F2FDC39Q36701736-4E859D1A-D40A-4E0C-8845-F1B6A0622ACFQ37416423-F9BD61BE-F5F0-45F0-BCB3-8FDEEB9E38CCQ38249892-33B1F028-0F49-4021-8133-6756A3E013E4Q38640910-7F211C2E-7535-4751-943C-FBBE0E49B970Q38770466-3666A985-7F08-4EE0-B83B-CBEB01FE23C3Q38777543-101F0D6B-284C-4C91-814D-7774865DEA38Q41540102-70DCEE6B-2DF3-45ED-B845-33E43B975306
P2860
Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@ast
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@en
type
label
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@ast
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@en
prefLabel
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@ast
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@en
P2093
P2860
P356
P1476
Efficacy and safety of combine ...... dney disease: a meta-analysis.
@en
P2093
Bertrand L Jaber
Ethan M Balk
Kamal Sewaralthahab
Nicolaos E Madias
Paweena Susantitaphong
Somchai Eiam-ong
P2860
P304
P356
10.1093/AJH/HPS038
P577
2013-01-07T00:00:00Z